Shahar Eyal, Lee Seungmin
Division of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, AZ, USA.
BMC Cardiovasc Disord. 2007 Jan 16;7:2. doi: 10.1186/1471-2261-7-2.
Population-based secular trends in survival of patients with congestive heart failure (CHF) are central to public health research on the burden of the syndrome.
Patients 35-79 years old with a CHF discharge code in 1995 or 2000 were identified in 22 Minneapolis-St. Paul hospitals. A sample of the records was abstracted (50% of 1995 records; 38% of 2000 records). A total of 2,257 patients in 1995 and 1,825 patients in 2000 were determined to have had a CHF-related hospitalization. Each patient was followed for one year to ascertain vital status.
The risk profile of the 2000 patient cohort was somewhat worse than that of the 1995 cohort in both sex groups, but the distributions of age and left ventricular ejection fraction were similar. Within one year of admission in 2000, 28% of male patients and 27% of female patients have died, compared to 36% and 27% of their counterparts in 1995, respectively. In various Cox regression models the average year effect (2000 vs. 1995) was around 0.75 for men and 0.95 to 1.00 for women. The use of angiotensin converting-enzyme inhibitors and beta-blockers was associated with substantially lower hazard of death during the subsequent year.
Survival of men who were hospitalized for CHF has improved during the second half of the 1990s. The trend in women was very weak, compatible with little to no change. Documented benefits of angiotensin converting-enzyme inhibitors and beta-blockers were evident in these observational data in both men and women.
基于人群的充血性心力衰竭(CHF)患者生存的长期趋势是该综合征负担的公共卫生研究的核心。
在明尼阿波利斯 - 圣保罗的22家医院中,识别出1995年或2000年有CHF出院代码的35 - 79岁患者。抽取了一部分记录样本(1995年记录的50%;2000年记录的38%)。确定1995年共有2257例患者,2000年有1825例患者因CHF相关住院。对每位患者随访一年以确定其生命状态。
在两个性别组中,2000年患者队列的风险状况比1995年队列稍差,但年龄和左心室射血分数的分布相似。2000年入院后一年内,男性患者中有28%死亡,女性患者中有27%死亡,而1995年相应的比例分别为36%和27%。在各种Cox回归模型中,男性的平均年份效应(2000年与1995年相比)约为0.75,女性为0.95至1.00。使用血管紧张素转换酶抑制剂和β受体阻滞剂与随后一年中显著较低的死亡风险相关。
20世纪90年代后半期,因CHF住院的男性患者生存率有所提高。女性的趋势非常微弱,几乎没有变化。血管紧张素转换酶抑制剂和β受体阻滞剂的已记录益处在这些观察数据中对男性和女性均很明显。